TABLE 1:

Patient characteristics

Patient (No.)123456
SexFMFFFM
Age (y)667849566776
Re-treated levelL1L2T6L1T10L1
Interoperative interval (days)16718822921
Approach
 Initial treatmentL*BLLLL
Repeat treatmentRRRLRR
Amount PMMA (cc)
 Initial treatment3.51551.11.23
Repeat treatment1.551.52.53.51.2
Initial Treatment
 Preoperative pain10101010710
 Postoperative pain050033
 Preoperative mobility020301
 Postoperative mobility010000
Repeat treatment
 Preoperative pain101010101010
 Postoperative pain812046
 Preoperative mobility121003
 Postoperative mobility010000
  • Note.—Pain was assessed using an 11-point scale (0–10), with 0 representing no pain and 10 representing “most pain ever experienced.” Mobility was assessed using a 5-point scale as follows: 0, walking without assistance; 1, walking with assistance; 2, wheelchair bound; 3, restricted to sitting in bed; 4, restricted to lying flat in bed. Follow-up was obtained between 1 week and 1 month postoperatively.

  • * Left unilateral transpediculate approach.

  • Bilateral transpediculate approach.

  • Right unilateral transpediculate approach.